AMGN Amgen Inc. Quick Ratio

Amgen Inc. demonstrates resilience to crises thanks to its patent-protected portfolio. The acid-test ratio calculation on GURU.Markets reflects current solvency, where 1.09 represents the latest level value. The company's high authority in medicine guarantees patient trust, while strict adherence to the cold chain during the transportation of biologics ensures uncompromising supply reliability.

AMGN: Amgen Corp Intermediate Coverage Ratio 07/04/2022 - 10/29/2026

Analytical breakdowns for Amgen Inc.

- market value and analyst target forecast:

Price Chart Amgen Corporation|AMGN - Consensus Target

- market capitalization data:

Market Capitalization Amgen Corporation|AMGN - Enterprise Value

- balance sheet net asset value indicators:

Accounting Value per Share Amgen|AMGN - Accounting Value of Company|Market Capitalization to Book Value Ratio amgen.com|AMGN - Aggregate Asset Value

- debt and liquidity data:

- earnings and valuation multiples information:

AMGN - Company Profit

Fundamental valuation:Amgen Corporation - AMGN

Liquidity analysis allows for the filtering of market noise by assessing a business's actual ability to meet its obligations. The metric aggregates cash and accounts receivable, intentionally excluding low-liquidity inventories. This quick ratio indicator on GURU.Markets visualizes the financial cushion of Amgen Inc. (AMGN). This is critical for the biopharmaceutical sector, where massive clinical trial expenditures require absolute solvency until patents are commercialized.

Key competitors